scholarly article | Q13442814 |
P50 | author | Ross L. Coppel | Q37378539 |
M. Eric Gershwin | Q73297886 | ||
P2093 | author name string | K Yoshida | |
T Hibi | |||
A A Ansari | |||
K Wakabayashi | |||
I R Mackay | |||
L S Wicker | |||
P S C Leung | |||
K Tsuneyama | |||
G-X Yang | |||
Y Moritoki | |||
Z-X Lian | |||
W M Ridgway | |||
P2860 | cites work | Liver autoimmunity triggered by microbial activation of natural killer T cells | Q24644772 |
Epigenetics in human autoimmunity. Epigenetics in autoimmunity - DNA methylation in systemic lupus erythematosus and beyond | Q33643660 | ||
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells | Q33916633 | ||
Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice | Q34360729 | ||
The regulatory, inflammatory, and T cell programming roles of interleukin-2 (IL-2). | Q34591170 | ||
Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid | Q34650472 | ||
The X and why of xenobiotics in primary biliary cirrhosis | Q35916081 | ||
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis | Q36238069 | ||
Type 1 diabetes genes and pathways shared by humans and NOD mice | Q36300649 | ||
Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses | Q36591648 | ||
Autophagy: highlighting a novel player in the autoimmunity scenario | Q36907987 | ||
Primer: epigenetics of autoimmunity | Q36925546 | ||
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border | Q36949181 | ||
The causes of primary biliary cirrhosis: Convenient and inconvenient truths | Q37039889 | ||
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease | Q37120134 | ||
The consequences of apoptosis in autoimmunity | Q37177836 | ||
Is autoimmunity a matter of sex? | Q37207818 | ||
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis | Q37388003 | ||
Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible | Q38341559 | ||
Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies | Q38355919 | ||
Monographs on fragrance raw materials | Q39844764 | ||
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) | Q39859200 | ||
Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis | Q40186249 | ||
Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse | Q40756950 | ||
Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization | Q43575984 | ||
Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis | Q43710194 | ||
Immunization with a Xenobiotic 6-Bromohexanoate Bovine Serum Albumin Conjugate Induces Antimitochondrial Antibodies | Q44432155 | ||
Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions | Q44598599 | ||
Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis | Q45877492 | ||
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex. | Q45948332 | ||
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis | Q46106529 | ||
In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset | Q46177088 | ||
Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function | Q46520605 | ||
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis | Q46553574 | ||
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice | Q46607067 | ||
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment | Q46795010 | ||
Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope | Q46837415 | ||
Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital | Q47418112 | ||
Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. | Q54024223 | ||
Mapping of the murine type 1 diabetes locus Idd20 by genetic interaction | Q57632624 | ||
Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse Chromosome 3 | Q60787773 | ||
Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB) | Q71254994 | ||
Abnormal expression of anion exchanger genes in primary biliary cirrhosis | Q72840980 | ||
Cytokine profile in the liver of primary biliary cirrhosis | Q73351173 | ||
Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis | Q73420872 | ||
Promotion of leukocyte transendothelial cell migration by chemokines derived from human biliary epithelial cells in vitro | Q73504637 | ||
Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study | Q74165295 | ||
Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis | Q74645181 | ||
Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain | Q80418640 | ||
Primary biliary cirrhosis | Q81246142 | ||
The autoimmune diabetes locus Idd9 regulates development of type 1 diabetes by affecting the homing of islet-specific T cells | Q83170079 | ||
P433 | issue | 3 | |
P921 | main subject | obesity | Q12174 |
ascending cholangitis | Q603644 | ||
immunization | Q1415366 | ||
P304 | page(s) | 577-586 | |
P577 | publication date | 2008-12-15 | |
P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
P1476 | title | Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization | |
P478 | volume | 155 |
Q37135580 | A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis |
Q26753195 | Adaptive immunity in the liver |
Q89795298 | Animal Models of Autoimmune Liver Diseases: a Comprehensive Review |
Q38244716 | Animal models in primary biliary cirrhosis and primary sclerosing cholangitis |
Q41221983 | Animal models of primary biliary cirrhosis |
Q38120662 | Autoimmune features in metabolic liver disease: a single-center experience and review of the literature |
Q34678839 | B cell depletion therapy exacerbates murine primary biliary cirrhosis |
Q37438364 | Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice |
Q34793579 | E. coli Induced Experimental Model of Primary Biliary Cirrhosis: At Last |
Q38905591 | Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity |
Q39792098 | Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice |
Q34513032 | Environmental factors in primary biliary cirrhosis |
Q41361892 | Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis |
Q38552201 | Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments. |
Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
Q37661371 | Experimental evidence on the immunopathogenesis of primary biliary cirrhosis |
Q46135644 | From pathogenesis to novel therapies in the treatment of primary biliary cholangitis |
Q36383011 | Genome-Wide Association Studies in Primary Biliary Cirrhosis |
Q58702534 | Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis |
Q34992359 | Immune-mediated bile duct injury: The case of primary biliary cirrhosis |
Q38018539 | Immunological orchestration of liver fibrosis |
Q38620686 | It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology |
Q34359990 | Liver immunology |
Q34623557 | Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches |
Q35203353 | Pathological features of new animal models for primary biliary cirrhosis |
Q56428272 | Primary biliary cirrhosis |
Q37783544 | Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes |
Q93140836 | Primary biliary cirrhosis: Family, genes, and bugs |
Q26799419 | Primary biliary cirrhosis: From bench to bedside |
Q34472336 | The autoimmunity of primary biliary cirrhosis and the clonal selection theory |
Q26992279 | The genetics of complex cholestatic disorders |
Q26801377 | The immunogenetics of primary biliary cirrhosis: A comprehensive review |
Q49036478 | The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model. |
Q43785645 | The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis |
Q36542397 | Therapeutic effect of cytotoxic T lymphocyte antigen 4/immunoglobulin on a murine model of primary biliary cirrhosis |
Q59384465 | Toward the molecular dissection of primary biliary cirrhosis |
Q34788943 | Toxicology of autoimmune diseases |
Q26772312 | Xenobiotics and loss of tolerance in primary biliary cholangitis |
Search more.